Zentalis Pharmaceuticals Market Sentiment

Zentalis Pharmaceuticals Inc

ZNTLNASDAQ

Trade with Public

$2.39

0.093.91%

最終更新: Oct 20, 6:29 PM

$2.43

0.135.65%

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Zentalis Pharmaceuticals Market Sentiment - Benzinga

Zentalis Pharmaceuticals Market Sentiment

Market sentiment signals for Zentalis Pharmaceuticals (ZNTL): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 7.4% short float

Options Flow▼ 2.59 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

14 analysts

Options Flow (P/C)

2.59

More puts — Bearish

203 calls · 525 puts

Avg Consensus PT

+255.1%

Highest Price Target

$20

+723.0%

Oppenheimer

Lowest Price Target

-9.5%

UBS

Short Interest

7.4%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 19, 2026	HC Wainwright & Co.	Andres Y. Maldonado—	+311.5%	$10 → $10	Maintained	Buy
Oct 5, 2026	Leerink Partners	Asthika Goonewardene—	+229.2%	$4 → $8	Assumes	Market Perform→Outperform
Sep 16, 2026	William Blair	Matt Phipps—	—	—	Initiate	Outperform
Jul 23, 2026	Rodman & Renshaw	——	+352.7%	$11	Initiate	Buy
Jul 17, 2026	Mizuho	Graig Suvannavejh—	+229.2%	$8	Initiate	Outperform
Apr 10, 2026	Guggenheim	Michael Schmidt—	+311.5%	$6 → $10	Maintained	Buy
Mar 27, 2026	Guggenheim	Michael Schmidt—	+146.9%	$6 → $6	Maintained	Buy
Nov 12, 2025	Morgan Stanley	Matthew Harrison—	+64.6%	$8 → $4	Maintained	Equal-Weight
Aug 7, 2025	Wells Fargo	Derek Archila—	+105.8%	$6 → $5	Maintained	Equal-Weight
May 15, 2025	Wedbush	Robert Driscoll—	+64.6%	$4 → $4	Maintained	Neutral
May 15, 2025	HC Wainwright & Co.	Andres Maldonado—	+311.5%	$10 → $10	Maintained	Buy
Mar 28, 2025	Wedbush	Robert Driscoll—	+64.6%	$4 → $4	Maintained	Neutral
Mar 27, 2025	HC Wainwright & Co.	Andrew Fein—	+311.5%	$10 → $10	Maintained	Buy
Mar 17, 2025	HC Wainwright & Co.	Andrew Fein—	+311.5%	$10 → $10	Maintained	Buy
Jan 30, 2025	Wells Fargo	Derek Archila—	+146.9%	$8 → $6	Maintained	Equal-Weight
Jan 29, 2025	HC Wainwright & Co.	Andrew Fein—	+311.5%	$20 → $10	Maintained	Buy
Jan 28, 2025	UBS	Eliana Merle—	-9.5%	$5 → $2	Maintained	Neutral
Nov 15, 2024	Guggenheim	Michael Schmidt—	+229.2%	$12 → $8	Maintained	Buy
Nov 15, 2024	HC Wainwright & Co.	Andrew Fein—	+723.0%	$20 → $20	Maintained	Buy
Sep 16, 2024	Oppenheimer	Matthew Biegler—	+723.0%	$20 → $20	Maintained	Outperform
Aug 12, 2024	Wedbush	Robert Driscoll—	+64.6%	$4	Upgrade	Underperform→Neutral
Aug 12, 2024	HC Wainwright & Co.	Andrew Fein—	+723.0%	$20 → $20	Maintained	Buy
Jun 20, 2024	UBS	Eliana Merle—	+105.8%	$28 → $5	Downgrade	Buy→Neutral
Jun 18, 2024	Wells Fargo	Derek Archila—	+270.4%	$29 → $9	Downgrade	Overweight→Equal-Weight
Jun 18, 2024	Stifel	Bradley Canino—	+311.5%	$32 → $10	Maintained	Buy